These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 20171187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M, Jank M, Motyl T.
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S, Goldschmidt-Clermont PJ, Dong C.
    Circ Res; 2004 Mar 19; 94(5):617-25. PubMed ID: 14739161
    [Abstract] [Full Text] [Related]

  • 6. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism.
    Zhu X, Topouzis S, Liang LF, Stotish RL.
    Cytokine; 2004 Jun 21; 26(6):262-72. PubMed ID: 15183844
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
    Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF.
    J Endocrinol; 2008 Feb 21; 196(2):235-49. PubMed ID: 18252947
    [Abstract] [Full Text] [Related]

  • 11. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu.
    Bender H, Wang Z, Schuster N, Krieglstein K.
    J Neurosci Res; 2004 Feb 01; 75(3):344-52. PubMed ID: 14743447
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myostatin regulates cell survival during C2C12 myogenesis.
    Ríos R, Carneiro I, Arce VM, Devesa J.
    Biochem Biophys Res Commun; 2001 Jan 19; 280(2):561-6. PubMed ID: 11162556
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
    Kamanga-Sollo E, Pampusch MS, White ME, Hathaway MR, Dayton WR.
    Exp Cell Res; 2005 Nov 15; 311(1):167-76. PubMed ID: 16214131
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
    Johnsen SA, Subramaniam M, Katagiri T, Janknecht R, Spelsberg TC.
    J Cell Biochem; 2002 Nov 15; 87(2):233-41. PubMed ID: 12244575
    [Abstract] [Full Text] [Related]

  • 20. Proteolytic processing of myostatin is auto-regulated during myogenesis.
    McFarlane C, Langley B, Thomas M, Hennebry A, Plummer E, Nicholas G, McMahon C, Sharma M, Kambadur R.
    Dev Biol; 2005 Jul 01; 283(1):58-69. PubMed ID: 15975431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.